Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescents

被引:57
作者
Grinstein, G [1 ]
Muzumdar, R [1 ]
Aponte, L [1 ]
Vuguin, P [1 ]
Saenger, P [1 ]
DiMartino-Nardi, J [1 ]
机构
[1] Albert Einstein Coll Med, Childrens Hosp Montefire Med Ctr, Div Pediat Endocrinol, Dept Pediat, Bronx, NY 10467 USA
关键词
type 2 diabetes mellitus obesity; minority groups; African-American adolescents; Caribbean-Hispanic adolescents;
D O I
10.1159/000072523
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We report the presentation and 5-year follow-up of 89 African-American (AA) and Caribbean-Hispanic (CH) youths with type 2 diabetes mellitus (T2DM) followed at the Montefiore Medical Center, Bronx, N.Y., USA, from 1990 to 2000. Methods: The medical records of 89 patients with T2DM diagnosed between 1990 and 2000 were reviewed. Results: Over a 10-year period, the number of pediatric patients less than 18 years of age diagnosed with T2DM at the Montefiore Medical Center increased tenfold. At presentation, the mean age was 14 +/- 2.3 years, the mean body mass index (BMI) was 34.4 +/- 9 kg/m(2), the female/male ratio was 1.6:1, and all these patients were pubertal. Acanthosis nigricans was present in 89% of the patients, polyuria and polydipsia occurred in 48%, weight loss occurred in 22%, and nearly 30% of the patients were asymptomatic at diagnosis. Diabetic ketoacidosis occurred in 5 patients. By 5 years after diagnosis, 45% of the patients were able to maintain an HgbA1C <7% with oral medications (metformin and/or glipizide); 18% required insulin (<0.4 U/kg/day) in addition to oral medications, and 37% did not require any medication. The mean insulin level, BMI and HgbA1C at the time of diagnosis did not predict treatment requirements for 3 years after diagnosis. Conclusions: Because the incidence of T2DM is increasing in adolescents, the natural history and optimal therapy for adolescents with T2DM need to be established.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 26 条
[1]  
*AM DIAB ASS, 1996, DIABETES CARE S1, V19, pS54
[2]  
Amer Diabet Assoc, 2000, DIABETES CARE, V23, pS32
[3]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[4]  
*CDCP, 1994, MMWR-MORBID MORTAL W, V43, P818
[5]   An overview of metformin in the treatment of type 2 diabetes mellitus [J].
Davidson, MB ;
Peters, AL .
AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01) :99-110
[6]   NIDDM-Y in first nation children in Canada [J].
Dean, H .
CLINICAL PEDIATRICS, 1998, 37 (02) :89-96
[7]  
DEAN HJ, 1992, CAN MED ASSOC J, V147, P52
[8]  
Deeb LC, 2000, DIABETES, V49, pA177
[9]   EFFICACY OF METFORMIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
DEFRONZO, RA ;
GOODMAN, AM ;
ABELOVE, W ;
REID, E ;
PITA, J ;
CALLAHAN, M ;
JOHNSON, D ;
PELAYO, E ;
PUGH, J ;
SHANK, M ;
GARZA, P ;
HAAG, B ;
KORFF, J ;
ANGELO, A ;
IZENSTEIN, B ;
VANDERLEEDEN, M ;
CATHCART, H ;
TIERNEY, M ;
BIGGS, D ;
KARAM, J ;
NOLTE, M ;
GAVIN, L ;
ELDER, MA ;
CORBOY, J ;
THWAITE, D ;
WONG, S ;
DAVIDSON, M ;
PETERS, A ;
DUNCAN, T ;
KERCHER, S ;
FISCHER, J ;
KIPNES, M ;
RADNICK, BJ ;
ROURA, M ;
ROQUE, J ;
MONTGOMERY, C ;
COLLUM, P ;
RUST, M ;
POHL, S ;
PFEIFER, M ;
ALLWEISS, P ;
LEICHTER, S ;
LEACH, P ;
GALLINA, D ;
MUSEY, V ;
BERKOWITZ, K ;
EASTMAN, R ;
TAYLOR, T ;
DELAPENA, MS ;
ZAWADSKI, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (09) :541-549
[10]   Secular increases in relative weight and adiposity among children over two decades: The Bogalusa Heart Study [J].
Freedman, DS ;
Srinivasan, SR ;
Valdez, RA ;
Williamson, DF ;
Berenson, GS .
PEDIATRICS, 1997, 99 (03) :420-426